Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORG 34517 as Adjunct in Major Depressive Disorder with Psychotic Features
NCT00226278Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Sep 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ORG-34517 in major depressive disorder (MDD) and psychotic disorder (3 arms), sponsored by Weill Cornell Medicine. Started Sep 2004; status: completed.
02
Drugs
ORG-34517
03
Conditions
major depressive disorder (MDD)psychotic disorder
Beyond the preview
Go deeper on NCT00226278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226278.